Clinical Trials Browser

Phase 2/3 × Withdrawn × Prostatic Neoplasms × Clear all

NCT03800784 2021-12-15

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Phase 2/3 Withdrawn

Prostatic Neoplasms

NCT00922129 2014-01-14

Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer

Phase 2/3 Withdrawn

Prostatic Neoplasms